The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01855581|
Recruitment Status : Unknown
Verified May 2013 by Yonsei University.
Recruitment status was: Recruiting
First Posted : May 16, 2013
Last Update Posted : May 16, 2013
Sedation and anesthesia for diagnostic imaging represents a rapidly growing field of practice, especially in children. Propofol is the most common sedative drug administered for MRI/CT. However, this drug is associated with adverse events, including pulmonary complications, and there has been no report on these complications in Korea.
The investigators reviewed 3739 charts of pediatric patients sedated for MRI/CT between January and November 2012.
In this study, the investigators will report the nature and frequency of adverse events associated with sedation for MRI/CT between January and November 2012.
|Condition or disease||Intervention/treatment|
|Children Requiring Sedation for MRI/CT||Drug: pediatric sedation (propofol, ketamine, etc)|
|Study Type :||Observational|
|Estimated Enrollment :||3739 participants|
|Study Start Date :||November 2012|
|Estimated Primary Completion Date :||July 2013|
|Estimated Study Completion Date :||October 2013|
Children requiring sedation for MRI/CT
Drug: pediatric sedation (propofol, ketamine, etc)
Presedation assessment was performed by hospitalists and pediatric sedation was performed by protocol in the sedation unit.
Data on demographics, primary illness, ASA, snoring history, URI symptom, medications used, procedure and recovery times, medication doses, outcomes of anesthesia, airway interventions and adverse events were collected retrospectively.
- Frequency of Adverse Events [ Time Frame: 24 hours ]The investigators will review all adverse events that are associated with pediatric sedation for MRI/CT
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01855581
|Korea, Republic of|
|Seoul, Korea, Republic of, 120-752|
|Contact: Eun Mi Kim 82-2-2227-3552 email@example.com|